3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
Cisplatin
3
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Radiation
2
Platinum
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cyclophosphamide
2
Congresses as Topic
2
Brachytherapy
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
1,2-diaminocyclohexaneplatinum II citrate
2
rocakinogene sifuplasmid
1
durvalumab
1
alovudine
1
adavosertib
1
Vaccines, Synthetic
1
VGX-3100
1
Sonazoid
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
MEDI0457
1
Interleukin-2
1
Immunoglobulin G
1
Fondaparinux
1
Fluorodeoxyglucose F18
1
Fentanyl
1
Disulfides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Vaginal Neoplasms
×
tipifarnib
×
Clear all
No trials found.